Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134297934> ?p ?o ?g. }
- W3134297934 endingPage "117" @default.
- W3134297934 startingPage "108" @default.
- W3134297934 abstract "Background: Dermatologic toxicity is the most common immune-related adverse effect of cancer immunotherapy.
 Methods: We retrospectively reviewed the health records of adult (≥18 years) melanoma patients who received ipilimumab, nivolumab, or pembrolizumab from January 1, 2011, through September 15, 2017, at Mayo Clinic. The χ2 test was used to assess the association between development of a cutaneous immune-related adverse effect and antitumoral response to the immune checkpoint inhibitors. Odds ratios were calculated with logistic regression models and were adjusted for sex and immunotherapeutic drugs. We described the various cutaneous immune-related adverse effects and assessed the response to immunotherapy (each patient’s objective clinical response was categorized as favorable [complete or partial response] or unfavorable). We then determined whether development of a cutaneous immune-related adverse effect was associated with the clinical response.
 Results: Of 690 melanoma patients, 232 (33.6%) had a cutaneous immune-related adverse effect. The most common effects were dermatitis (21.4%), pruritus (5.5%), and vitiligo (4.2%). Median (range) time to onset of dermatitis was 3 (0-7) weeks; lichenoid dermatitis, 12 (6-18) weeks; and vitiligo, 40 (12-96) weeks. Development of a cutaneous immune-related adverse effect was significantly associated with favorable clinical response.
 Conclusions: Development of cutaneous immune-related adverse effects is associated with favorable responses to nivolumab, ipilimumab, pembrolizumab, and ipilimumab plus nivolumab therapy in patients with metastatic melanoma." @default.
- W3134297934 created "2021-03-15" @default.
- W3134297934 creator A5010365006 @default.
- W3134297934 creator A5030233600 @default.
- W3134297934 creator A5034570655 @default.
- W3134297934 creator A5036950376 @default.
- W3134297934 creator A5082719040 @default.
- W3134297934 date "2021-03-06" @default.
- W3134297934 modified "2023-09-26" @default.
- W3134297934 title "Associations of Cutaneous Immune-Related Adverse Effects of Immunotherapy With Treatment Response in Patients With Metastatic Melanoma" @default.
- W3134297934 cites W1585093095 @default.
- W3134297934 cites W1913801405 @default.
- W3134297934 cites W1977582499 @default.
- W3134297934 cites W1982488143 @default.
- W3134297934 cites W1990675339 @default.
- W3134297934 cites W2014647470 @default.
- W3134297934 cites W2128035403 @default.
- W3134297934 cites W2132916434 @default.
- W3134297934 cites W2137349687 @default.
- W3134297934 cites W2148706732 @default.
- W3134297934 cites W2152897456 @default.
- W3134297934 cites W2153942285 @default.
- W3134297934 cites W2156353875 @default.
- W3134297934 cites W2160834915 @default.
- W3134297934 cites W2177405394 @default.
- W3134297934 cites W2312343228 @default.
- W3134297934 cites W2329871425 @default.
- W3134297934 cites W2342126794 @default.
- W3134297934 cites W2507729480 @default.
- W3134297934 cites W2531852397 @default.
- W3134297934 cites W2549481046 @default.
- W3134297934 cites W2549697938 @default.
- W3134297934 cites W2551387057 @default.
- W3134297934 cites W2562942923 @default.
- W3134297934 cites W2563758465 @default.
- W3134297934 cites W2586361162 @default.
- W3134297934 cites W2586640730 @default.
- W3134297934 cites W2588081028 @default.
- W3134297934 cites W2596627582 @default.
- W3134297934 cites W2606806644 @default.
- W3134297934 cites W2610600861 @default.
- W3134297934 cites W2619609185 @default.
- W3134297934 cites W2624444627 @default.
- W3134297934 cites W2755059520 @default.
- W3134297934 cites W2763723894 @default.
- W3134297934 cites W2764116502 @default.
- W3134297934 cites W2782072747 @default.
- W3134297934 cites W2783695707 @default.
- W3134297934 cites W2786816161 @default.
- W3134297934 cites W2787912635 @default.
- W3134297934 cites W2788113440 @default.
- W3134297934 cites W2796061183 @default.
- W3134297934 cites W2808854560 @default.
- W3134297934 cites W2883399237 @default.
- W3134297934 doi "https://doi.org/10.25251/skin.5.2.5" @default.
- W3134297934 hasPublicationYear "2021" @default.
- W3134297934 type Work @default.
- W3134297934 sameAs 3134297934 @default.
- W3134297934 citedByCount "1" @default.
- W3134297934 countsByYear W31342979342022 @default.
- W3134297934 crossrefType "journal-article" @default.
- W3134297934 hasAuthorship W3134297934A5010365006 @default.
- W3134297934 hasAuthorship W3134297934A5030233600 @default.
- W3134297934 hasAuthorship W3134297934A5034570655 @default.
- W3134297934 hasAuthorship W3134297934A5036950376 @default.
- W3134297934 hasAuthorship W3134297934A5082719040 @default.
- W3134297934 hasBestOaLocation W31342979341 @default.
- W3134297934 hasConcept C121608353 @default.
- W3134297934 hasConcept C126322002 @default.
- W3134297934 hasConcept C143998085 @default.
- W3134297934 hasConcept C16005928 @default.
- W3134297934 hasConcept C197934379 @default.
- W3134297934 hasConcept C203014093 @default.
- W3134297934 hasConcept C2777658100 @default.
- W3134297934 hasConcept C2777701055 @default.
- W3134297934 hasConcept C2779980618 @default.
- W3134297934 hasConcept C2780030458 @default.
- W3134297934 hasConcept C2780057760 @default.
- W3134297934 hasConcept C2781433595 @default.
- W3134297934 hasConcept C502942594 @default.
- W3134297934 hasConcept C71924100 @default.
- W3134297934 hasConcept C8891405 @default.
- W3134297934 hasConceptScore W3134297934C121608353 @default.
- W3134297934 hasConceptScore W3134297934C126322002 @default.
- W3134297934 hasConceptScore W3134297934C143998085 @default.
- W3134297934 hasConceptScore W3134297934C16005928 @default.
- W3134297934 hasConceptScore W3134297934C197934379 @default.
- W3134297934 hasConceptScore W3134297934C203014093 @default.
- W3134297934 hasConceptScore W3134297934C2777658100 @default.
- W3134297934 hasConceptScore W3134297934C2777701055 @default.
- W3134297934 hasConceptScore W3134297934C2779980618 @default.
- W3134297934 hasConceptScore W3134297934C2780030458 @default.
- W3134297934 hasConceptScore W3134297934C2780057760 @default.
- W3134297934 hasConceptScore W3134297934C2781433595 @default.
- W3134297934 hasConceptScore W3134297934C502942594 @default.
- W3134297934 hasConceptScore W3134297934C71924100 @default.
- W3134297934 hasConceptScore W3134297934C8891405 @default.
- W3134297934 hasIssue "2" @default.